In scalded rats, KPV peptide injection might prevent the decrease in glucocorticoid receptor binding capacity in hepatic cytosol 12 h after scald.
In plain wordsIn scalded rats, KPV injections might stop the drop in liver glucocorticoid receptor binding.
- Peptide
- KPV
- Outcome
- IncreaseGlucocorticoid receptor binding capacity (Rt) in hepatic cytosol
- Study
ratn: not reported in source
Wistar rats with 35% immersion scald- Outcome group
- Receptor activity and mechanism · Endocrine and hormones
- Studied dose
- Dose not stated
Measurements
- GR binding capacity (Rt)
- 263.46 fmol/mg of protein
- KPV peptide, scalded rats
Source sentences
The injections of anti-rat TNFalpha (257.80+/-12.82fmol/mg of protein), IL-1beta antibody (254.46+/-21.21fmol/mg of protein), alpha-melanocyte-stimulating hormone (278.32+/-7.76fmol/mg of protein) and KPV peptide (263.46+/-17.46fmol/mg of protein) might prevent the Rt of GR from decreasing in hepati…
1 context sentence(design, population, supporting numbers)
Male Wistar rats (weight range, 180-200g) received a 35% total body surface area immersion scald and were randomly divided to receive either tumor necrosis factor alpha (TNFalpha), interleukin-1beta (IL-1beta), polyclonal antibody (pAb), alpha-MSH, Ac-D-Lys-L-Pro-D-Val (KPV peptide), or saline (control).